Search

everythinglearnresearchcommunity

for

Search:↓

Endocrine disruptors may cause early hair loss.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Neurosteroids show promise for treating epilepsy and more research is needed.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Prolactin affects when mice shed and grow hair.

Prolactin affects when mice shed and grow hair.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Early hormones shape sex-specific differences in rat glands.

Finasteride changes hormone levels and certain proteins in rats, but these effects can be reversed after stopping the drug.

Hormones control reproduction and are crucial for body balance.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Healthy women tend to lose more hair in July and April, and the least in February.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.